Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Consolidated Net Profit

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Consolidated Net Profit ₹1,388 Cr₹715 Cr₹170 Cr₹441 Cr₹461 Cr

What is the latest Consolidated Net Profit of NATCO PHARMA ?

The latest Consolidated Net Profit ratio of NATCO PHARMA is ₹1,388 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹1,388 Cr
Mar2023₹715 Cr
Mar2022₹170 Cr
Mar2021₹441 Cr
Mar2020₹461 Cr

How is Consolidated Net Profit of NATCO PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹1,388 Cr
94.09
Mar2023 ₹715 Cr
320.76
Mar2022 ₹170 Cr
-61.44
Mar2021 ₹441 Cr
-4.32
Mar2020 ₹461 Cr -

Compare Consolidated Net Profit of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,823.5 Cr 4.5% 7.1% -11.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,032.0 Cr 0.9% 2.2% 23.9% Stock Analytics
DIVIS LABORATORIES ₹162,252.0 Cr 3.3% 4.7% 58% Stock Analytics
CIPLA ₹124,457.0 Cr 0.5% 2% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,425.0 Cr -0.4% 2.8% 24.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,152.8 Cr -0.8% -0.4% 0.8% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

4.5%

7.1%

-11.6%

SENSEX

0.9%

3%

8.9%


You may also like the below Video Courses